Study guide

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology

Key Takeaways Explain This Topic AI

Cerebrospinal fluid is formed at approximately 500 mL/day by choroid plexuses and reabsorbed by arachnoid villi; lumbar puncture requires a four-tube protocol where Tube 2 (microbiology) is maintained strictly at room temperature to preserve fastidious pathogens like Neisseria meningitidis.

Traumatic lumbar puncture exhibits progressive clearing of blood across sequential tubes, fibrin clot formation, clear supernatant upon immediate centrifugation, and absent siderophages, whereas subarachnoid hemorrhage features uniform blood distribution, defibrinated non-clotting fluid, true xanthochromia, and erythrophagocytosis.

Manual cell counts utilize the standard hemocytometer formula: Cells/µL = (Cells counted × Dilution factor) / (Squares counted × 0.1 mm depth); normal adult CSF contains 0–5 mononuclear WBCs/µL, with neutrophilic pleocytosis indicating acute bacterial meningitis.

Blood-brain barrier disruption is identified by a CSF/Serum Albumin Index > 9.0, while intrathecal immunoglobulin synthesis is confirmed by a CSF IgG Index > 0.70 and the presence of two or more discrete CSF oligoclonal bands absent in paired serum (pathognomonic for Multiple Sclerosis).

Acute bacterial, tuberculous, and fungal meningitis demonstrate markedly depressed CSF glucose (< 40 mg/dL or CSF:plasma ratio < 0.40) and elevated lactate (> 35 mg/dL), whereas viral meningitis typically maintains normal glucose and lactate (< 25 mg/dL).

Last updated: October 2026

Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology

Cerebrospinal fluid (CSF) analysis represents one of the most critical emergency diagnostic procedures performed in the clinical microscopy laboratory. Because the central nervous system (CNS) is enclosed within a rigid osseous vault and shielded by the blood-brain barrier (BBB), biochemical, cytological, and microbiological alterations in the CSF provide direct insight into life-threatening infections, intracranial hemorrhages, demyelinating syndromes, and neoplastic invasions.

1. Anatomy, Physiology, and Formation of CSF

Cerebrospinal fluid is a specialized physiological ultrafiltrate of plasma modified by active transport secretions that bathes the brain, ventricular system, and spinal subarachnoid space.

Choroid Plexus and Filtration Dynamics

CSF is produced primarily (approximately 70% to 80%) by the choroid plexuses —convoluted networks of specialized ependymal cells and fenestrated capillaries located within the lateral, third, and fourth ventricles. The remaining 20% to 30% originates as interstitial fluid generated across cerebral capillary walls and ependymal linings.

Production Rate: Approximately 500 mL/day (roughly 0.35 to 0.40 mL/min, or 20 mL/hr in adults).

Total Circulating Volume:

Adults: 90 to 150 mL (meaning the entire volume is renewed and turned over 4 to 5 times every 24 hours).

Neonates: 10 to 60 mL .

Reabsorption Mechanism: CSF flows through the ventricular system (from lateral ventricles through the interventricular foramina of Monro to the third ventricle, down the cerebral aqueduct of Sylvius into the fourth ventricle, and out through the midline foramen of Magendie and paired lateral foramina of Luschka into the subarachnoid space). Reabsorption occurs via bulk flow through the arachnoid villi (arachnoid granulations) directly into the superior sagittal sinus and associated venous lacunae. Reabsorption is a passive, one-way pressure-dependent process driven by a positive hydrostatic gradient between the subarachnoid space and the venous sinus system.

The Blood-Brain Barrier (BBB)

The BBB is an anatomical and physiological filtration barrier formed by:

Non-fenestrated capillary endothelial cells joined by continuous complex tight junctions (zonula occludens) .

A thick, continuous capillary basement membrane.

Surrounding pericytes and the overlapping end-feet (foot processes / podocytes ) of astrocytes.

The BBB strictly regulates the bidirectional transit of hydrophilic solutes, macromolecules, electrolytes, and immunoglobulins between systemic blood and the neural parenchyma. Small lipophilic molecules (e.g., carbon dioxide, oxygen, ethanol) diffuse freely, whereas glucose and amino acids require specific carrier-mediated transport proteins. High-molecular-weight plasma proteins (such as albumin, immunoglobulins, and fibrinogen) are largely excluded under physiological conditions.

2. Lumbar Puncture Collection and Multi-Tube Protocol

Lumbar puncture (LP) is performed by a physician under strict aseptic technique. The patient is placed in either the lateral decubitus position or an upright seated position with the spine flexed to widen the interspinous intervals. Puncture is executed at the L3–L4 or L4–L5 intervertebral space , safely below the conus medullaris (the anatomical termination of the adult spinal cord at L1–L2).

Opening Pressure

Before fluid is collected, an in-line manometer measures the opening pressure:

Normal adult opening pressure: 90 to 180 mm H2O (in lateral decubitus).

Normal pediatric opening pressure: 10 to 100 mm H2O .

Elevated opening pressure (> 200–250 mm H2O): Seen in acute bacterial meningitis, intracranial tumors, cerebral edema, subarachnoid hemorrhage, and idiopathic intracranial hypertension (pseudotumor cerebri).

Standard Four-Tube Sequential Distribution Protocol

Fluid is collected sequentially into sterile, non-pyrogenic, screw-capped polypropylene tubes numbered 1 through 4. Adherence to tube allocation is paramount to eliminate cross-contamination and pre-analytical artifacts:

Tube Number Laboratory Section Key Tests Performed Temperature & Handling Requirements

Tube 1 Clinical Chemistry & Serology Glucose, Total Protein, Lactate, Albumin, IgG, VDRL Stored frozen (-20°C) or refrigerated (2–8°C). Tissue debris or initial puncture blood does not alter chemistry assays.

Tube 2 Microbiology Gram stain, Bacterial/Fungal culture, Acid-fast stain Maintained strictly at ROOM TEMPERATURE (20–25°C) ; NEVER refrigerated , as cold exposure kills fastidious organisms ( N. meningitidis , H. influenzae ).

Tube 3 Hematology Total cell count, RBC count, WBC differential Maintained refrigerated (2–8°C) if analysis cannot begin within 30 minutes; has the lowest risk of puncture-induced blood contamination.

Tube 4 Special Diagnostics / Cytology Cytocentrifugation for malignancy, Flow cytometry, Viral PCR Handled according to test specifications; provides uncontaminated fluid for sensitive molecular and cytological analyses.

Important

Room Temperature Storage for Tube 2: Fastidious meningeal pathogens—particularly Neisseria meningitidis and Haemophilus influenzae —are extremely cold-labile. Placing Tube 2 into a standard 2–8°C laboratory refrigerator can destroy viable bacteria within 15 to 30 minutes, producing false-negative microbiological cultures.

3. Traumatic Tap vs. Subarachnoid Hemorrhage (SAH)

A critical diagnostic conundrum in clinical microscopy is differentiating between gross blood introduced inadvertently by needle puncture of the epidural venous plexus ( traumatic puncture ) versus blood originating from an intracranial bleed ( subarachnoid hemorrhage ).

Loading diagram...

The Four Classical Discriminatory Criteria

Visual Clearing Across Sequential Tubes:

Traumatic Tap: The blood concentration is highest in Tube 1 and demonstrates dramatic, progressive visual clearing in Tubes 2, 3, and 4.

Subarachnoid Hemorrhage: Blood is distributed homogeneously and shows completely uniform red coloration across all sequential tubes.

In Vitro Clot Formation:

Traumatic Tap: Introduces whole systemic blood containing intact plasma coagulation factors and fibrinogen . Consequently, traumatic CSF frequently forms partial or complete gelatinous fibrin clots or delicate pellicles upon standing.

Subarachnoid Hemorrhage: Blood present within the subarachnoid space undergoes rapid in vivo defibrination by intrinsic meningeal and subarachnoid fibrinolytic enzymes. Therefore, true SAH fluid does not clot in vitro .

Centrifuged Supernatant Appearance and True Xanthochromia:

Definition: Xanthochromia is the pink, orange, or yellow discoloration of the cell-free CSF supernatant resulting from the enzymatic breakdown of hemoglobin.

Traumatic Tap: When centrifuged immediately (within 1 hour of collection), the supernatant is crystal clear and colorless (water-clear), because intact erythrocytes have not had time to undergo substantial in vitro lysis.

Subarachnoid Hemorrhage: The supernatant exhibits true xanthochromia , which develops in vivo within 2 to 4 hours post-hemorrhage and persists for 2 to 4 weeks. Hemoglobin undergoes sequential enzymatic degradation:

Oxyhemoglobin (Pink to Orange): Released upon erythrocyte lysis within 2 to 4 hours; maximal at 24 to 48 hours.

Methemoglobin (Brown to Yellow-Brown): Formed by the oxidation of heme iron from Fe2+ to Fe3+; typical of loculated subdural or intracerebral bleeds.

Unconjugated Bilirubin (Canary Yellow): Synthesized within meningeal macrophages by heme oxygenase within 8 to 12 hours post-hemorrhage. Spectrophotometric scanning between 350 nm and 600 nm demonstrates diagnostic absorption peaks at 415 nm (oxyhemoglobin) and 450–460 nm (bilirubin).

Microscopic Cytological Findings on Cytospin Preparations:

Traumatic Tap: Shows intact, fresh, biconcave erythrocytes. Macrophages containing engulfed red cells or hemosiderin are completely absent.

Subarachnoid Hemorrhage: Exhibits erythrophagocytosis (macrophages actively engulfing intact erythrocytes) from about 4 hours after the bleed. From roughly 48 hours (2 to 4 days), intracellular hemoglobin is converted into golden-brown, refractile hemosiderin granules (staining deep blue with Prussian blue iron stain; siderophages ). From about 2 weeks onward, golden-yellow, iron-free hematoidin crystals (rhomboid crystalline aggregates related to bilirubin) appear within histiocytes.

4. Microscopic Examination and Hemocytometer Counts

CSF cell counts must be performed within 30 minutes of lumbar puncture because leukocytes (especially granulocytes) rapidly lyse at room temperature; approximately 40% of WBCs disintegrate within 2 hours post-collection.

Neubauer Hemocytometer Counting Protocol

Manual cell counts are conducted using an Improved Neubauer hemocytometer. If the specimen is clear, counts are performed undiluted. If gross blood or profound turbidity is present, calibrated dilutions are prepared using a micropipette:

Cells/ μ L = Number of Cells Counted × Dilution Factor Number of 1 mm 2 Large Squares Counted × 0.1 mm Depth \text{Cells/}\mu\text{L} = \frac{\text{Number of Cells Counted} \times \text{Dilution Factor}}{\text{Number of } 1\text{ mm}^2 \text{ Large Squares Counted} \times 0.1\text{ mm Depth}} Cells/ μ L = Number of 1 mm 2 Large Squares Counted × 0.1 mm Depth Number of Cells Counted × Dilution Factor ​

Diluting Fluids:

Total Cell / RBC Count: Normal saline (0.85% NaCl) is used to disperse cells without lysis.

Total WBC Count: A 3% glacial acetic acid solution tinted with methylene blue or crystal violet ( Türck's solution ) is used to lyse all non-nucleated erythrocytes while staining the nuclei of leukocytes for rapid optical identification.

Normal Cellular Reference Intervals

Normal Adult CSF: 0 to 5 WBCs/µL (100% mononuclear cells: approximately 70% lymphocytes and 30% monocytes ; 0% neutrophils ).

Normal Neonatal CSF (up to 28 days): 0 to 30 WBCs/µL (predominantly mononuclear cells, with up to 20% segmented neutrophils considered physiologically acceptable due to birth trauma and immature BBB permeability).

Normal RBC Count: 0 RBCs/µL in any age group.

Differential Smear Preparation

A stained differential smear should never be performed directly from an unconcentrated wet preparation. Specimen concentration is accomplished using a specialized cytocentrifuge (Cytospin) at 700 to 1,000 rpm for 5 to 10 minutes. A drop of 22% bovine serum albumin is added to stabilize delicate cell membranes and prevent distortion. The resulting air-dried monolayer is stained with Wright-Giemsa stain .

Pleocytosis Patterns and Pathological Correlations

An abnormal elevation of white blood cells within the CSF is termed pleocytosis : ┌─ Neutrophilic (>80% PMNs) ─────► Acute Bacterial Meningitis, early viral

│

CSF Pleocytosis Patterns ─────────┼─ Lymphocytic / Mononuclear ───► Viral (aseptic), TB, Fungal, Multiple Sclerosis

  • │
  • └─ Eosinophilic (≥10% Eos) ─────► Angiostrongylus cantonensis, VP shunts, Coccidioides

Neutrophilic Pleocytosis (> 80% neutrophils): Hallmarked by acute bacterial meningitis (WBC counts typically 1,000 to 10,000/µL or higher). Also observed during the hyperacute stage (first 24 to 48 hours) of viral meningitis, early tuberculous meningitis, cerebral abscess rupture, and following intracranial hemorrhage.

Lymphocytic Pleocytosis: Predominance of small, mature lymphocytes and reactive (transformed) lymphocytes. Characteristic of viral (aseptic) meningoencephalitis, neurosyphilis, tuberculous meningitis, fungal meningitis, and active demyelinating diseases such as Multiple Sclerosis.

Eosinophilic Pleocytosis (≥ 10% eosinophils): Classical in parasitic invasions of the CNS, notably Angiostrongylus cantonensis (the rat lungworm, endemic to Southeast Asia and the Pacific, causing human eosinophilic meningoencephalitis via raw snail/crustacean ingestion), Taenia solium (neurocysticercosis), Gnathostoma spinigerum , fungal infections ( Coccidioides immitis ), and mechanical malfunction/allergic reaction to ventriculoperitoneal (VP) shunts .

Plasma Cells: Completely absent in normal CSF. Their presence indicates intense localized humoral immune response: Multiple Sclerosis, subacute sclerosing panencephalitis (SSPE), neurosyphilis, and lymphocytic choriomeningitis.

Malignant Cells: Clustered cells showing nuclear pleomorphism, hyperchromasia, multinucleation, and high nuclear-to-cytoplasmic (N:C) ratios represent primary CNS neoplasms (e.g., medulloblastoma, ependymoma) or metastatic carcinomas (e.g., breast, bronchogenic, melanoma, acute lymphoblastic leukemia [ALL], lymphoma).

  • 5. Chemical Analysis of CSF
  • 1. CSF Total Protein

Under physiological conditions, large serum proteins are excluded by the blood-brain barrier. The normal adult reference interval for CSF total protein is 15 to 45 mg/dL (0.15 to 0.45 g/L).

Neonates: Up to 150 mg/dL due to increased BBB permeability and immaturity.

Elderly (> 60 years): Up to 60 mg/dL .

Causes of Elevated CSF Protein

Severe infectious meningitis (bacterial, tuberculous, fungal), where levels frequently exceed 100 to 500 mg/dL.

Subarachnoid hemorrhage and traumatic tap (every 1,000 RBCs/µL introduced into the CSF contributes an artifactual increase of approximately 1 mg/dL of total protein).

Spinal subarachnoid block ( Froin's syndrome ): Characterized by the diagnostic triad of marked xanthochromia, hyperproteinemia (> 500 to 1,000 mg/dL), and rapid spontaneous clotting of the fluid in the collection tube due to stagnation below a compressive spinal cord lesion.

Guillain-Barré Syndrome (GBS): Exhibits classic albuminocytologic dissociation —a marked elevation of CSF protein (100 to 400 mg/dL) accompanied by a completely normal CSF leukocyte count (0 to 5 WBCs/µL).

CSF/Serum Albumin Index (BBB Permeability)

Because albumin is synthesized exclusively by hepatocytes and cannot cross the intact BBB, its presence in CSF serves as an objective marker of blood-brain barrier integrity:

CSF/Serum Albumin Index = CSF Albumin (mg/dL) Serum Albumin (g/dL) \text{CSF/Serum Albumin Index} = \frac{\text{CSF Albumin (mg/dL)}}{\text{Serum Albumin (g/dL)}} CSF/Serum Albumin Index = Serum Albumin (g/dL) CSF Albumin (mg/dL) ​

Interpretation:

< 9.0: Intact, fully functional blood-brain barrier.

9.0 to 14.0: Slight BBB impairment.

14.1 to 30.0: Moderate BBB impairment.

> 30.0: Severe BBB breakdown (e.g., severe acute bacterial meningitis, extensive trauma).

CSF IgG Index (Intrathecal Synthesis)

To differentiate between immunoglobulins entering the CSF passively across a leaky BBB versus immunoglobulins produced autonomously within the CNS by intrathecal plasma cells, the CSF IgG Index is calculated:

CSF IgG Index = CSF IgG (mg/dL) / Serum IgG (g/dL) CSF Albumin (mg/dL) / Serum Albumin (g/dL) \text{CSF IgG Index} = \frac{\text{CSF IgG (mg/dL)} / \text{Serum IgG (g/dL)}}{\text{CSF Albumin (mg/dL)} / \text{Serum Albumin (g/dL)}} CSF IgG Index = CSF Albumin (mg/dL) / Serum Albumin (g/dL) CSF IgG (mg/dL) / Serum IgG (g/dL) ​

Normal Reference Range: 0.30 to 0.70 .

Diagnostic Value (> 0.70): An IgG index greater than 0.70 provides quantitative proof of active intrathecal IgG synthesis , seen in > 90% of patients with Multiple Sclerosis (MS), neurosyphilis, and post-infectious encephalitis.

Oligoclonal Banding and Myelin Basic Protein (MBP)

Oligoclonal Banding (OCB): Evaluated by high-resolution agarose gel electrophoresis combined with isoelectric focusing (IEF) and immunoblotting on simultaneously collected, paired CSF and serum specimens.

Pathognomonic Finding for Multiple Sclerosis: Presence of ≥ 2 discrete gamma-globulin bands in the CSF that are completely ABSENT in the patient's paired serum (sensitivity > 90–95%).

If identical bands appear in both CSF and serum, it represents systemic gammopathy passing across a damaged BBB rather than CNS demyelination.

Myelin Basic Protein (MBP): A major structural protein of the myelin sheath. Levels > 4 ng/mL reflect active demyelination and acute axonal destruction during MS exacerbations.

2. CSF Glucose

CSF glucose enters via passive diffusion and facilitated carrier-mediated transport. Under normal physiological conditions, CSF glucose concentration equilibrates to approximately 60% to 70% of the simultaneous blood glucose concentration (normal absolute value: 50 to 80 mg/dL ).

A blood glucose specimen is drawn about 2 hours before the lumbar puncture , because CSF glucose lags behind blood glucose while the two compartments equilibrate.

Marked Hypoglycorrhachia (< 40 mg/dL or CSF:Serum Glucose Ratio < 0.40): Definitive feature of acute bacterial meningitis , tuberculous meningitis , and fungal meningitis . The profound drop results from a combination of active glycolytic consumption by microorganisms and leukocytes, and impaired hexose transport across damaged endothelial BBB cells.

Normal CSF Glucose (Ratio > 0.60): Characteristic of viral (aseptic) meningitis .

3. CSF Lactate

CSF lactate levels reflect anaerobic metabolism within the CNS and are completely independent of systemic blood lactate concentrations because lactate does not freely cross the intact BBB.

Normal Adult Range: 10 to 22 mg/dL (1.1 to 2.4 mmol/L).

Lactate > 35 mg/dL: Strong clinical indicator of bacterial, tuberculous, or fungal meningitis .

Lactate < 25 mg/dL: Strong clinical indicator of viral meningitis .

Clinical Utility: Measuring CSF lactate is valuable in rapidly discriminating partially treated bacterial meningitis (where antibiotic exposure may clear Gram stains but lactate remains elevated > 35 mg/dL) from viral aseptic meningitis.

4. CSF Glutamine

Synthesized by astroglial cells by conjugating ammonia with alpha-ketoglutarate, CSF glutamine functions as a primary cerebral detoxifying mechanism for toxic ammonia.

Normal Range: 8 to 18 mg/dL .

Levels > 35 mg/dL: Directly correlate with the onset of severe hepatic encephalopathy , decompensated cirrhosis, and pediatric Reye syndrome (frequently presenting with intracranial hypertension and coma).

6. Microbiology and Differential Diagnostic Matrix

Microbiological examination must be executed immediately on concentrated Tube 2 sediment obtained after centrifugation at 1,500 × g for 15 minutes.

Key Stains and Microbiological Procedures

Gram Stain: Detects common etiologic agents: Streptococcus pneumoniae (lancet-shaped Gram-positive diplococci), Neisseria meningitidis (Gram-negative diplococci with flattened opposing sides), Haemophilus influenzae (pleomorphic Gram-negative coccobacilli), and Listeria monocytogenes (small Gram-positive bacilli displaying tumbling motility).

Acid-Fast Stains (Ziehl-Neelsen / Kinyoun / Fluorochrome Auramine-O): Detects Mycobacterium tuberculosis . Examination of the cobweb / pellicle clot formed upon refrigerated overnight standing of tuberculous CSF yields the highest sensitivity.

India Ink / Nigrosin Wet Mount & Cryptococcal Antigen (CrAg): Detects Cryptococcus neoformans . India ink provides negative contrast highlighting the thick polysaccharide capsule around budding yeast cells (sensitivity ≈ 50%); Cryptococcal Antigen (CrAg) latex agglutination or lateral flow immunoassay yields > 95–98% sensitivity and specificity.

CSF-VDRL (Venereal Disease Research Laboratory): The only non-treponemal serological test officially approved and recommended by the CDC for the diagnosis of neurosyphilis on CSF. CSF-VDRL is highly specific; however, because of low sensitivity, a negative CSF-VDRL does not rule out neurosyphilis. Rapid Plasma Reagin (RPR) is NOT suitable for CSF analysis.

Meningitis Differential Diagnostic Matrix

Parameter Normal Adult Reference Acute Bacterial Meningitis Viral (Aseptic) Meningitis Tuberculous Meningitis Fungal Meningitis ( C. neoformans )

Opening Pressure 90 to 180 mm H2O Markedly elevated (> 200–300) Normal to slightly elevated Markedly elevated Markedly elevated

Appearance Crystal clear, colorless Cloudy, turbid, purulent Clear to faintly hazy Clear or opalescent; pellicle clot Clear, hazy, or viscous

Total WBC Count 0 to 5/µL Markedly elevated (1,000 to 10,000+/µL) Mild to moderate (50 to 500/µL) Moderate (100 to 500/µL) Mild to moderate (50 to 500/µL)

Predominant Cell Mononuclear (L: 70%, M: 30%) Neutrophils (> 80%) Lymphocytes (> 80%) Lymphocytes / Monocytes Lymphocytes

Protein Concentration 15 to 45 mg/dL Markedly elevated (> 100–500) Normal or mildly elevated (< 100) Markedly elevated (> 100–500) Elevated (> 100–500)

Glucose Concentration 50 to 80 mg/dL Markedly decreased (< 40) Normal (> 50) Markedly decreased (< 40) Decreased (< 40)

CSF:Serum Glucose Ratio 0.60 to 0.70 Markedly decreased (< 0.40) Normal (> 0.60) Decreased (< 0.30–0.40) Decreased (< 0.40)

Lactate Concentration 10 to 22 mg/dL Markedly elevated (> 35) Normal (< 25 mg/dL) Markedly elevated (> 35) Elevated (> 35 mg/dL)

Confirmatory Testing Non-reactive Positive Gram stain and bacterial culture Viral RT-PCR (enterovirus, HSV, VZV) Acid-fast stain; mycobacterial culture; NAAT India ink (+ in 50%); CrAg latex (+ in >95%)